Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections
Latest Information Update: 19 Dec 2023
At a glance
- Drugs Tedizolid (Primary)
- Indications Bone and joint infections
- Focus Adverse reactions; Therapeutic Use
- 01 Mar 2023 Status changed from active, no longer recruiting to completed.
- 22 Feb 2021 Status changed from recruiting to active, no longer recruiting.
- 03 Jun 2020 Planned End Date changed from 1 Jan 2021 to 1 Jan 2022.